G. Freyer et al., Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations, ANN ONCOL, 12(10), 2001, pp. 1461-1465
Background: As shown in a previous study, the knowledge of the genetic risk
in individuals belonging to families at risk of medullary-thyroid carcinom
a (MTC) could be associated with impaired quality of life (QoL).
Patients and methods: In the present study, we compared the QoL scores obta
ined in the same period with the subjective quality of life profile (SQLP):
in 82 individuals at risk of MTC who had been tested for Ret-mutations; in
200 women at risk of familial breast/ovarian cancer syndrome (BOC); and in
a control population of 3501 healthy volunteers.
Results:Significant differences were observed in favour of healthy voluntee
rs as well as individuals at risk of MTC, over women at risk of BOC (mean s
cores: 0.89, 0.85, and 0.64, respectively, P less than or equal to 0.001),
but QoL scores were not statistically different between individuals at risk
of MTC and the control population (P = 0.2). However, they were significan
tly inferior in the subgroup of germline Ret-mutation carriers, as compared
to the control population (mean scores: 0.73 and 0.89, P = 0.04). In the l
atter, the relationships with the children and the family were the most imp
ortant facets of their QoL.
Conclusion: Our results confirm the potentially negative impact of the know
ledge of the genetic risk of cancer and its consequences in terms of morbid
ity and follow-up, on the QoL in people followed at oncogenetic visits.